2525 EAST NORTH CAROLINA HIGHWAY 54, DURHAM, NC
Expands Board Expertise with Appointment of Scott Coward and Paul Kuznik
Announces Second Quarter 2026 Financial Results and Provides Business Update
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Announces Pricing of Public Offering of Common Stock
Investor Presentation
Humacyte, Inc. Increases Authorized Shares to 550 Million
Other Events
Q2
Q1
FY 2025
Q3
FY 2024
Prospectus filed pursuant to Rule 424(b)(5)
Registration Statement for Securities to be Offered to Employees
Prospectus filed pursuant to Rule 424(b)(3)
Effectiveness Notice
Definitive Proxy Statement
PRE 14A
Additional Proxy Materials
Statement of Changes in Beneficial Ownership
Initial Statement of Beneficial Ownership
Notification Filed by a National Security Exchange
Correspondence
Submission Upload